Utah Medical Products offers $75 for up to 650K shares

The offer is scheduled to remain open until 5:00 p.m. New York City time on October 7, unless UTMD extends it.

Rhea-AI Filing Summary

Utah Medical Products, Inc. is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The offer is scheduled to expire at 5:00 p.m. New York City time on October 7, unless extended by the company. UTMD clarified that October 7 falls on a Wednesday, correcting prior announcements that identified it as Tuesday.

Key Figures

Shares offered for purchase: Up to 650,000 shares Purchase price: $75.00 per share Scheduled expiration time: 5:00 p.m. New York City time +1 more

4 metrics

Shares offered for purchase Up to 650,000 shares Issuer tender offer

Purchase price $75.00 per share Issuer tender offer

Scheduled expiration time 5:00 p.m. New York City time October 7, unless extended by UTMD

Scheduled expiration date October 7 The company clarified that the date falls on a Wednesday

Key Terms

issuer tender offer, Offer to Purchase, Letter of Transmittal

3 terms

issuer tender offer regulatory

"issuer tender offer subject to Rule 13e-4"

An issuer tender offer is when a company offers to buy back its own shares directly from shareholders at a set price for a limited time, much like a store running a cash-for-items promotion. It matters to investors because it can raise the share price, change how much of the company each remaining shareholder owns, signal management’s view of the company’s value, and affect taxable events and liquidity for those who sell or hold.

Offer to Purchase regulatory

"SEC Form TO Offer to Purchase"

An offer to purchase is a formal proposal from one party to buy a specific amount of shares or assets from another party at a set price. It matters to investors because it signals interest in acquiring ownership and can influence the value or control of a company. Think of it as someone putting forward a clear, serious offer to buy something they find valuable.

Letter of Transmittal regulatory

"Offer to Purchase and Letter of Transmittal"

A letter of transmittal is a written form investors use when sending physical stock certificates or electronic ownership documents to a company or its agent to surrender shares, tender them in an offer, or claim payment or replacement securities. It acts like a packing slip that lists what is enclosed, gives instructions on how the transfer should be handled, and provides proof of the transaction—important for ensuring investors receive the correct payment or new securities without delay or dispute.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many UTMD shares is the company offering to buy, and at what price?

Utah Medical Products, Inc. is offering to purchase up to 650,000 shares of common stock at $75.00 per share.

When does the UTMD tender offer expire?

The offer is scheduled to expire at 5:00 p.m. New York City time on October 7, unless extended by UTMD.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/25/2026 - 12:46 PM Accepted by SEC EDGAR 09/25/2026 - 12:45 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE TO

TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1)

OF THE SECURITIES EXCHANGE ACT OF 1934

Utah Medical Products, Inc.

(Name of Subject Company (Issuer))

Utah Medical Products, Inc.

(Names of Filing Persons (Issuer and Offeror))

Common Stock, $0.01 par value per share

(Title of Class of Securities)

917488108

(CUSIP Number of Class of Securities)

Kevin L. Cornwell

Chairman & CEO

Utah Medical Products, Inc.

7043 S 300 W

Midvale, UT 84047

Telephone: (801) 566-1200

(Name, Address and Telephone Number of Person Authorized to

Receive Notices and Communications on Behalf of Filing Persons)

x Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

	¨	third-party tender offer subject to Rule 14d-1.
	x	issuer tender offer subject to Rule 13e-4.
	¨	going-private transaction subject to Rule 13e-3.
	¨	amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐

If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:

	¨	Rule 13e-4(i) (Cross-Border Issuer Tender Offer)
	¨	Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)

Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date

Contact:  Brian Koopman September 25, 2026 

   (801) 566-1200 

Salt Lake City, Utah – Utah Medical Products, Inc. (Nasdaq: UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter of Transmittal filed with the SEC at  

https://www.sec.gov/Archives/edgar/data/706698/000109690626001428/0001096906-26-001428-index.html

The Offer is scheduled to expire at 5:00 p.m. New York City time, on October 7, unless extended by UTMD. October 7 is a Wednesday.  Some of UTMD’s previous announcements indicated incorrectly that October 7 is a Tuesday.

The Company regrets any confusion caused by the error.

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients.  For more information about Utah Medical Products, Inc., visit UTMD’s website at www.utahmed.com.